Industry Update by Dusko Ilic: Regulations, approvals, acquisitions…

Latest developments compiled from 1 July until 31 August 2014 Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from non-academic institutions from 1 July until 31 August 2014, scheduled to be published in Volume 9 Issue 6 of Regenerative Medicine. Green light BioTime BioTime (CA, USA; www.biotimeinc.com) has received notice from the FDA’s Center for Devices and Radiologic Health that Premviaâ„¢ has been cleared for marketing as a Class II medical device. Premviaâ„¢is the first FDA-cleared member of BioTime’s HyStem family of hydrogels, which are designed to mimic...